Renal & Secondary Hypertension Clinical Evaluation & Targeted Management

1. The Bidirectional Axis of Kidneys and Blood Pressure

The relationship between the kidneys and systemic arterial blood pressure is uniquely bidirectional: uncontrolled hypertension is the second leading cause of end-stage renal disease worldwide, while chronic kidney disease is simultaneously the most common cause of secondary, resistant hypertension.

At our clinic, Dr. Fayaz Ahmad Wani provides systematic diagnostic evaluation for secondary etiologies, rational polypharmacy for drug-resistant cases, and strict blood pressure titration to protect the heart, brain, and kidneys from irreversible end-organ damage.

2. When to Suspect Secondary Hypertension

While 90% of adult hypertension is essential (primary), secondary hypertension should be aggressively investigated in patients exhibiting any of the following clinical features:

• Onset of significant hypertension before age 30 or sudden development after age 55.
• Previously well-controlled blood pressure that rapidly escalates or becomes refractory.
• Severe hypertension (Stage 2: BP ≥ 160/100 mmHg) with unexplained hypokalemia (low potassium).
• Significant deterioration of renal function (>30% creatinine elevation) following initiation of ACE inhibitors or ARBs.
• Episodic headache, palpitations, and diaphoresis (sweating).
• Significant abdominal or flank bruits, or severe obstructive sleep apnea symptoms.

3. Secondary Causes Evaluated & Managed

• Renal Artery Stenosis (Renovascular Hypertension): Atherosclerotic narrowing or fibromuscular dysplasia of renal arteries diagnosed via Renal Doppler ultrasound and CT/MR Angiography.
• Chronic Kidney Disease (Renal Parenchymal Hypertension): Sodium retention, volume expansion, and renin hypersecretion due to parenchymal nephron destruction.
• Primary Aldosteronism: Autonomous aldosterone hypersecretion from adrenal adenoma or hyperplasia evaluated via Plasma Aldosterone-to-Renin Ratio (ARR).
• Pheochromocytoma & Paraganglioma: Catecholamine-producing neuroendocrine tumors screened via 24-hour urinary or plasma free metanephrines.
• Cushing's Syndrome & Endocrine Disorders: Adrenal glucocorticoid excess or thyroid abnormalities.

4. Managing Resistant Hypertension

Resistant hypertension is formally diagnosed when blood pressure remains above 140/90 mmHg despite concurrent, adherence-verified use of three antihypertensive agents of different classes (one of which must be a diuretic), or requires four or more medications to achieve control.

Dr. Wani applies standardized KDIGO and ESH guidelines: excluding white-coat hypertension through 24-hour Ambulatory Blood Pressure Monitoring (ABPM), switching to long-acting thiazide-like diuretics (Chlorthalidone / Indapamide), adding mineralocorticoid receptor antagonists (Spironolactone / Eplerenone), and guiding lifestyle sodium restriction to achieve target organ protection.

Medical Notice: The information presented on this page is for clinical education and patient guidance. Kidney disease, hypertension, and transplant regimens require individualized diagnostic evaluation, serum laboratory monitoring, and physician consultation. In acute emergencies, call 112 or visit the nearest tertiary emergency department.